1) Eczema  
2) Consumer medical phone App (San Leandro & Mt. View locations)
3) Gout 

4) Type 2 Diabetes
5) Lupus (Fremont location)


Study participants will receive the study drug, and all study related

testing and examinations at no cost. Compensation for time and travel may be available.

1) Eczema study


If you have been diagnosed with eczema, you may be eligible to participate in a clinical research study of an investigational ointment.  This research study is being conducted to compare the safety and effectiveness of a study ointment for eczema to that of a marketed ointment or a placebo.

2) Consumer medical (phone) app


We are looking for participants to join a consumer medical app study.  In order to participate in this study you will need to be comfortable with giving a urine sample.

The studies are scheduled Monday through Friday and will last around 30-90 minutes.  The study will take place in San Leandro and Mountain View.  Selected participants who complete the full test will receive compensation.

Participants need to be OK with the following:

- Must be at least 18-year old
- Allowing us to record the session
- Not require an assistive device or software to use a mobile device
- Read and understand English and willing to sign study consent
- Giving urine sample (off camera)
- Must have experience using an Apple iPhone 

3) Gout study 

This is a 5-9 year study to evaluate the safety of Febuxostat (Uloric) and Allopurinol. Study-related medical care and services are provided at no cost to study participants. Compensation for time and travel will be provided.

You may qualify to participate if you:


Female 55 years or older
Male 50 years or older
Have gout


4) Type 2 Diabetes

This is a 2 year study to evaluate add-on medications to Metformin. Study-related medical care and services are provided at no cost to study participants. Compensation for time and travel will be provided.

You may qualify to participate if you:
Have Type 2 Diabetes

Current patient of the study doctor


​5) Lupus (Fremont Location)

A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab.


Future studies include: GERD, Weight Loss, Coronary Heart Disease, Type 2 Diabetes, , Back Pain,  Erectile Dysfunction, Hypertension, COPD, IBS, Opioid Constipation, Arthritis

To find out more information about a specific study, please call 925-413 1451 or email studies@westcoastresearch.com.  Our staff will be able to tell you more about the research study and answer your questions.


Join a study